Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
342
archived clinical trials in
Postherpatic Neuralgia

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated:  9/12/2013
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated:  9/12/2013
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Status: Enrolling
Updated: 9/12/2013
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Premier Research
1657
mi
from 43215
Phoenix, AZ
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Premier Research
1657
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Neurovations
2090
mi
from 43215
Napa, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Neurovations
2090
mi
from 43215
Napa, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Northern California Research
2043
mi
from 43215
Sacramento, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Northern California Research
2043
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Neurological Research Institute
1985
mi
from 43215
Santa Monica, CA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Neurological Research Institute
1985
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Meridien Research
789
mi
from 43215
Brooksville, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Meridien Research
789
mi
from 43215
Brooksville, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Fpa Clinical Research
810
mi
from 43215
Kissimmee, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Fpa Clinical Research
810
mi
from 43215
Kissimmee, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Suncoast Clinical Research, Inc.
810
mi
from 43215
New Port Richey, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Suncoast Clinical Research, Inc.
810
mi
from 43215
New Port Richey, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Compass Research LLC
795
mi
from 43215
Orlando, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Compass Research LLC
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Sarasota Pain Medicine Research
879
mi
from 43215
Sarasota, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Sarasota Pain Medicine Research
879
mi
from 43215
Sarasota, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Meridien Research
830
mi
from 43215
Tampa, FL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Meridien Research
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Dekalb Neurology Associates, LLC
433
mi
from 43215
Decatur, GA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Dekalb Neurology Associates, LLC
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Medex Healthcare Research, Inc.
274
mi
from 43215
Chicago, IL
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Medex Healthcare Research, Inc.
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Integrated Clinical Trial Services, Inc.
572
mi
from 43215
West Des Moines, IA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Integrated Clinical Trial Services, Inc.
572
mi
from 43215
West Des Moines, IA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
IRC Clinics, Inc.
343
mi
from 43215
Towson, MD
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
IRC Clinics, Inc.
343
mi
from 43215
Towson, MD
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Boston Clinical Trials, INC.
643
mi
from 43215
Boston, MA
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Boston Clinical Trials, INC.
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Michigan Head Pain & Neurological Institute
163
mi
from 43215
Ann Arbor, MI
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Michigan Head Pain & Neurological Institute
163
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Albuquerque Clinical Trials
1333
mi
from 43215
Albuquerque, NM
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Albuquerque Clinical Trials
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Clinical Trials of America Inc
304
mi
from 43215
Hickory, NC
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Clinical Trials of America Inc
304
mi
from 43215
Hickory, NC
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Lynn Health Science Institute
849
mi
from 43215
Oklahoma City, OK
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Lynn Health Science Institute
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Pain Specialist of Charleston, P.A.
523
mi
from 43215
Mt. Pleasant, SC
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Pain Specialist of Charleston, P.A.
523
mi
from 43215
Mt. Pleasant, SC
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Nashville Neuroscience Group, PC
332
mi
from 43215
Nashville, TN
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Nashville Neuroscience Group, PC
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Trinity Clinical Research
362
mi
from 43215
Tullahoma, TN
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Trinity Clinical Research
362
mi
from 43215
Tullahoma, TN
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
ClinRx Research LLC
896
mi
from 43215
Plano, TX
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
ClinRx Research LLC
896
mi
from 43215
Plano, TX
Click here to add this to my saved trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  12/31/2013
Progressive Clinical Research
1137
mi
from 43215
San Antonio, TX
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 12/31/2013
Progressive Clinical Research
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
A Phase 2A, Randomized, Blinded, Placebo- and Active-controlled, 2-Period Crossover Study to Assess the Analgesic Efficacy, Safety, and Tolerability of ADL5747 in Subjects With Postherpetic Neuralgia
Status: Enrolling
Updated:  7/8/2015
Laszlo J. Mate, MD
928
mi
from 43215
West Palm Beach, FL
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
A Phase 2A, Randomized, Blinded, Placebo- and Active-controlled, 2-Period Crossover Study to Assess the Analgesic Efficacy, Safety, and Tolerability of ADL5747 in Subjects With Postherpetic Neuralgia
Status: Enrolling
Updated: 7/8/2015
Laszlo J. Mate, MD
928
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
1174
mi
from 43215
Boulder, CO
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
1174
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated:  10/20/2015
4608
mi
from 43215
Vienna,
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
Status: Enrolling
Updated: 10/20/2015
4608
mi
from 43215
Vienna,
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Arizona Research Center
1658
mi
from 43215
Phoenix, AZ
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Arizona Research Center
1658
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Torrance Clinical Research
1982
mi
from 43215
Lomita, CA
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Torrance Clinical Research
1982
mi
from 43215
Lomita, CA
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Compass Research LLC
795
mi
from 43215
Orlando, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Compass Research LLC
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Commonwealth Biomedical Research, LLC
301
mi
from 43215
Madisonville, KY
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Commonwealth Biomedical Research, LLC
301
mi
from 43215
Madisonville, KY
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Finger Lakes Clinical Research
356
mi
from 43215
Rochester, NY
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Finger Lakes Clinical Research
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Radiant Research, Inc.
109
mi
from 43215
Akron, OH
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Radiant Research, Inc.
109
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Alpine Clinical Research Center
1175
mi
from 43215
Boulder, CO
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Alpine Clinical Research Center
1175
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Brain Matters Research
948
mi
from 43215
Delray Beach, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Brain Matters Research
948
mi
from 43215
Delray Beach, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Comprehensive Clinical Development, Inc.
842
mi
from 43215
St Petersburg, FL
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Comprehensive Clinical Development, Inc.
842
mi
from 43215
St Petersburg, FL
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Drug Studies America
422
mi
from 43215
Marietta, GA
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Drug Studies America
422
mi
from 43215
Marietta, GA
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Analgesic Solutions
627
mi
from 43215
Natick, MA
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Analgesic Solutions
627
mi
from 43215
Natick, MA
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
QUEST Research Institute
176
mi
from 43215
Farmington Hills, MI
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
QUEST Research Institute
176
mi
from 43215
Farmington Hills, MI
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
The Center for Pharmaceutical Research, P.C.
620
mi
from 43215
Kansas City, MO
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
The Center for Pharmaceutical Research, P.C.
620
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Medex Healthcare Research, Inc
401
mi
from 43215
St. Louis, MO
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Medex Healthcare Research, Inc
401
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
PMG Research of Winston-Salem
306
mi
from 43215
Winston-Salem, NC
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
PMG Research of Winston-Salem
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
COR Clinical Research
849
mi
from 43215
Oklahoma City, OK
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
COR Clinical Research
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated:  11/6/2015
FutureSearch Trials of Neurology
1065
mi
from 43215
Austin, TX
Crossover Post-herpetic Neuralgia (PHN)
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Status: Enrolling
Updated: 11/6/2015
FutureSearch Trials of Neurology
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials